Article Details
Retrieved on: 2022-09-06 12:25:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... will start enrollment later this fall: receiving either a 100 µg dose of ABNCoV2 or a 30 µg adult booster dose of Pfizer/BioNTech's Comirnaty.
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here